Xiamen is home to over 1,500 biopharmaceutical companies, with more than 400 based in Haicang District alone. The district accounts for over 50% of the province's total medical device output value and product registrations, solidifying its position as the core hub of Fujian's biopharmaceutical industry.

To accelerate the R&D and production processes of biopharmaceutical enterprises, Xiamen has become the first in China to innovate the regulatory mechanisms for drugs and medical devices, obtaining provincial-level approval and review authorities in the city.

Since the implementation of this reform, administrative licensing applications at the relevant service windows have increased by over 80% annually, helping Xiamen's Biopharmaceutical Port rise from 15th to 13th in the national rankings of biopharmaceutical industrial parks.